All stocks ยท KOBO
KB

KOBO BIOTECH LIMITED

KOBO BSE Drug Manufacturers - Specialty & Generic Healthcare

Kobo Biotech Limited manufactures active pharmaceutical ingredients based on fermentation technology in India. The company was formerly known as Avon Lifesciences Limited and changed its name to Kobo Biotech Limited in โ€ฆ

ISIN INE881A01015
Listed โ€”
Quarters tracked โ€”
Filings 20 docs

About

Kobo Biotech Limited manufactures active pharmaceutical ingredients based on fermentation technology in India. The company was formerly known as Avon Lifesciences Limited and changed its name to Kobo Biotech Limited in October 2020. The company was incorporated in 1993 and is based in Mumbai, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in โ€” check back soon.

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
Sales 103.00103.00404.00287.00162.00
Expenses 104.00104.00361.00238.00133.00
Operating Profit -1.00-1.0043.0049.0029.00
OPM % -0.90-0.9011.0017.0018.00
Other Income 0.000.000.000.000.00
Interest 24.0024.0018.0021.0013.00
Depreciation 10.0010.0010.0011.006.00
Profit before tax -34.00-34.0015.0018.0010.00
Tax % 2.002.008.0011.000.00
Net Profit -35.00-35.0014.0016.0010.00
EPS in Rs -15.48-15.486.226.724.37
Dividend Payout % 0.000.000.0015.0023.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
Equity Capital 22.0022.0022.0022.0022.00
Reserves 31.0031.0065.0051.0039.00
Borrowings 179.00179.00182.00118.00131.00
Other Liabilities 163.00163.00142.00154.0057.00
Total Liabilities 396.00396.00412.00346.00250.00
Fixed Assets 104.00104.00108.00100.00110.00
CWIP 2.002.003.0013.000.00
Investments 0.000.000.000.000.00
Other Assets 290.00290.00301.00232.00140.00
Total Assets 396.00396.00412.00346.00250.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2015Mar 2014Mar 2013Mar 2012
Cash from Operating Activity 7.007.0037.0064.00
Cash from Investing Activity -5.00-5.00-7.00-14.00
Cash from Financing Activity -13.00-13.00-38.00-27.00
Net Cash Flow -11.00-11.00-9.0023.00
Free Cash Flow 2.002.0030.0049.00
CFO/OP % -789.00-789.0090.00135.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
Debtor Days 671.00671.00185.00187.00143.00
Inventory Days 300.00300.0066.0079.00179.00
Days Payable 468.00468.00111.00203.00115.00
Cash Conversion Cycle 503.00503.00140.0062.00207.00
Working Capital Days 73.0098.0025.0028.0088.00
ROCE % -4.00-4.0014.0020.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95
DIIs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.66 0.66
Public 55.05 55.05 55.05 55.05 55.05 55.04 55.05 55.05 55.06 54.39 54.37 54.39
No. of Shareholders 7,734 7,977 7,970 7,947 7,929 7,873 7,542 6,916 6,788 6,767 6,530 6,478

Corporate Actions

3 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 21 Sep 2012 โ€” โ€” 1.00
Dividend 22 Jul 2011 โ€” โ€” 1.00
Dividend 23 Sep 2010 โ€” โ€” 1.00

Announcements

5 filings